trial

The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia

NCTId NCT01493622
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 78 (actual)
Sponsored by Central South University
Primary completion 2011-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
78 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2010-06
Primary completion
2011-11
Eligibility
ALL · 18 Years · 40 Years

Interventions & indications

Drugs
Minocycline

Sponsors

Central South UniversityLead Sponsor

Investigators

1
Zhao J PingPrincipal Investigator

Sites

1 total
Kunming, China

Facts & assertions

4 sourced
Enrollment
78
Phase
PHASE4
Primary Completion Date
2011-11
Status
COMPLETED
relationships
The graph out of here
drug
Minocycline
drug
lead_sponsor
Central South University
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Zhao J Ping
person